Advanced Cell Technology, Inc.Worcester, MA United States
Company Description
No need to choose between embryonic and adult stem cells -- Advanced Cell Technology (ACT) works with both to develop cellular therapies designed to regenerate human tissue. The company has developed three product platforms based on stem-cell technology. They are retinal pigment epithelial therapy (RPE) for the treatment of degenerative retinal disease; myoblast stem cell therapy to treat chronic heart failure and other heart problems; and the hemangioblast platform (HG) for the treatment of blood and cardiovascular diseases. Though the company is focused on bringing the clinical-stage technologies to market, it is also continuing to conduct research for other regenerative medicine treatments.
| 381 Plantation St. | Phone: 508-756-1212 | http://www.advancedcell.com |
| Worcester, MA 01605 | 
Map This Company | |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Advanced Cell Technology, Inc. Rankings
Executives
| 7 executives listed for Advanced Cell Technology, Inc.'s Worcester, MA location. | ||
| Interim Chairman and CEO | Gary Rabin | |
|---|---|---|
| Chief Scientific Officer | Robert Lanza | |
| Director | AlanShapiro | |
Financials
| Company Type | Public - OTC: ACTC Single Location |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 30 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Advanced Cell Technology, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
